Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Gattermann

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
Leukemia Research|November 6, 2012
Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blastsAnna Maassen, Corinna Strupp, Aristoteles Giagounidis, et al.
Annals of Hematology|March 31, 2016
Causes of death in 2877 patients with myelodysplastic syndromesKathrin Nachtkamp, Romina Stark, Corinna Strupp, et al.
Cancer|December 3, 2005
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemiaAndrea Kuendgen, Mathias Schmid, Richard Schlenk, et al.
Haematologica|December 6, 2006
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromesUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Molecular Therapy Oncolytics|December 13, 2021
A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cellsArthur Bister, Tabea Ibach, Corinna Haist, et al.
Cancers|July 29, 2023
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk ScoreTobias Silzle, Sabine Blum, Annika Kasprzak, et al.
Haematologica|July 4, 2007
Chronic myelomonocytic leukemia in the light of the WHO proposalsUlrich Germing, Corinna Strupp, Sabine Knipp, et al.
Haematologica|February 16, 2015
Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromesMaryam Hejazi, Angela R Manser, Julia Fröbel, et al.
European Journal of Haematology|October 26, 2011
Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjangeNorbert Gattermann, Andrea Jarisch, Rudolf Schlag, et al.
Blood Cells, Molecules & Diseases|June 1, 2006
X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patternsManuel Aivado, Norbert Gattermann, Astrid Rong, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Leukemia Research|November 6, 2012
Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blastsAnna Maassen, Corinna Strupp, Aristoteles Giagounidis, et al.
Annals of Hematology|March 31, 2016
Causes of death in 2877 patients with myelodysplastic syndromesKathrin Nachtkamp, Romina Stark, Corinna Strupp, et al.
Cancer|December 3, 2005
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemiaAndrea Kuendgen, Mathias Schmid, Richard Schlenk, et al.
Haematologica|December 6, 2006
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromesUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Molecular Therapy Oncolytics|December 13, 2021
A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cellsArthur Bister, Tabea Ibach, Corinna Haist, et al.
Cancers|July 29, 2023
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk ScoreTobias Silzle, Sabine Blum, Annika Kasprzak, et al.
Haematologica|July 4, 2007
Chronic myelomonocytic leukemia in the light of the WHO proposalsUlrich Germing, Corinna Strupp, Sabine Knipp, et al.
Haematologica|February 16, 2015
Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromesMaryam Hejazi, Angela R Manser, Julia Fröbel, et al.
European Journal of Haematology|October 26, 2011
Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjangeNorbert Gattermann, Andrea Jarisch, Rudolf Schlag, et al.
Blood Cells, Molecules & Diseases|June 1, 2006
X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patternsManuel Aivado, Norbert Gattermann, Astrid Rong, et al.
Pageof 16